4 Results for "

tumour immunotherapy

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "tumour immunotherapy" in MCE Product Catalog:

Cat. No.: HY-111786
CAS No.: 1258595-14-0
Purity:  ≥98.0%
Research Areas:  

Cancer

LHC-165 is a TLR7 agonist. LHC-165 has potential to used in study of solid tumors .
loading...
    loading...
Cat. No.: HY-163448
Target:  

Phosphatase

Research Areas:  

Cancer

NPP1-IN-2 (compound 3h) is a potent and selective Ectonucleotide pyrophosphatase/phosphodiesterase-1 (NPP1) inhibitor with IC50 values of 0.55, 3.73 µM for NPP1, NPP3, respectively .
loading...
    loading...
Cat. No.: HY-161518
Target:  

PD-1/PD-L1

Research Areas:  

Cancer

PD-1/PD-L1-IN-44 (Compound 22) selectively inhibits PD-1/PD-L1 proteins (IC50=1.21 nM). PD-1/PD-L1-IN-44 inhibits tumor growth without toxicity in animal models and increases CD8 + cell infiltration .
loading...
    loading...
Cat. No.: HY-111786R
CAS No.: 1258595-14-0
Research Areas:  

Cancer

LHC-165 (Standard) is the analytical standard of LHC-165 (HY-111786). This product is intended for research and analytical applications. LHC-165 is a TLR7 agonist. LHC-165 has potential to used in study of solid tumors .
loading...
    loading...